Skip to main content
BrainCited

Curcumin pour Age-Related Cognitive Decline

B

A UCLA 18-month RCT found bioavailable curcumin improved memory test performance and reduced brain amyloid/tau PET signals in non-demented adults. Bioavailability of the formulation is the key factor for effectiveness.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

En conclusion

A UCLA 18-month RCT found bioavailable curcumin improved memory test performance and reduced brain amyloid/tau PET signals in non-demented adults. Bioavailability of the formulation is the key factor for effectiveness.

Key Study Findings

Review
Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging.
Dose: None vs: None Outcome: None Effet: None None

Population: aging individuals with cognitive decline

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d vs: None Outcome: Cognitive decline in AD Effet: None None

Population: Alzheimer's disease patients

Review
Plant-based strategies against aging: Focus on bioactive compounds from medicine-food homology plants.
Dose: None vs: None Outcome: None Effet: None None

Population: None

Systematic Review
Curcumin and Dementia: A Systematic Review of Its Effects on Oxidative Stress and Cognitive Outcomes …
Dose: None vs: Various dementia models Outcome: Oxidative stress, inflammation, cognitive outcomes Effet: MDA reduced 100%; cognition improved ~80% None

Population: Rodent dementia models (29 studies)

Key Statistics

10

Études

800

Participants

Mixed

B

Note

Referenced Papers

Molecules (Basel, Switzerland) 2025 16 citations
Behavioral neuroscience 2022 2 citations
Roczniki Panstwowego Zakladu … 2021 45 citations
Molecules (Basel, Switzerland) 2020 36 citations
International journal of … 2018 126 citations
Acta bio-medica : … 2018 103 citations
Advances in nutrition … 2017 215 citations
Molecular neurobiology 2010 145 citations
The Proceedings of … 2002 191 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
500-2,000 mg/day of enhanced bioavailability form
cognitivesupport:
90-180 mg/day Theracurmin or equivalent

Limite supérieure : Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Positive --
None -- Mixed --
None -- Mixed --
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
None -- Mixed --
None -- Positive --
100 mg/kg each 4 weeks Positive --
None -- Positive --

Moment optimal de prise : With meals containing fat and black pepper (piperine) for absorption

Safety & Side Effects

Effets indésirables signalés

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Headache
  • Skin rash (rare)
  • Yellow staining of teeth with powder forms

Interactions connues

  • Anticoagulants (may increase bleeding risk)
  • Antidiabetic drugs (may enhance blood sugar lowering)
  • CYP450 substrates (may affect drug metabolism)
  • Iron supplements (curcumin may chelate iron)

Apport maximal tolérable : Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Curcumin help with Age-Related Cognitive Decline?
Based on 10 studies with 800 participants, there is moderate evidence from clinical studies that Curcumin may support Age-Related Cognitive Decline management. Our evidence grade is B (Good Evidence).
How much Curcumin should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 500-2,000 mg/day of enhanced bioavailability form. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Skin rash (rare), Yellow staining of teeth with powder forms. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Age-Related Cognitive Decline?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 800 total participants. The overall direction of effect is mixed.

Related Evidence

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.